article thumbnail

Psychedelics Present Unique Ethical Challenges

Pharmacy Times

Sa’ed Al-Olimat, PharmD, co-founder of the Psychedelic Pharmacists Association, discussed the future of psychedelic medicines and the unique ethical challenges they present.

122
122
article thumbnail

Investigators Present New Data About HPV Vaccine, Supporting Its Use

Pharmacy Times

Data from the BROADEN and PROGRESS studies were presented at the International Papillomavirus Conference 2024 in Edinburgh, UK, from November 12 to 15.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Lomecel-B CLEARMIND Phase 2a Trial Results to Be Presented at AAIC

Pharmacy Times

Safety and efficacy findings on Lomecel-B will be presented at the upcoming 2024 Alzheimer’s Association International Conference, which will be held July 28 to August 1.

139
139
article thumbnail

Victor Alves Presenting at the 2024 Northeast Conference

OctariusRx

OctariusRx President and Consultant Pharmacist Victor Alves is presenting “Medication management when done right, keeps patient harm and deficiencies out of sight” at the 2024 Northeast Conference, presented by the Massachusetts Association of Ambulatory Surgery Centers. Contact us for assistance.

86
article thumbnail

How to Make a Pharmacy Poster Presentation

Find Your Script

Purchase Pharmacy Poster Presentation Templates here! The post How to Make a Pharmacy Poster Presentation appeared first on Find Your Script by Dr. Jessica Louie. We talk passive income and simplifying on this channel to combat stress and burnout. What to include? How to format it? Link to purchase. Best step to take? How to print it?

130
130
article thumbnail

EC approves GSK’s Menveo vaccine presentation for IMD

Pharmaceutical Technology

The EC has granted approval for presentation of GSK's Menveo vaccine (MenACWY) for invasive meningococcal disease (IMD).

article thumbnail

High-Risk Pediatric Patients With Antiphospholipid Syndrome Present Risk of Severe Health Issues

Pharmacy Times

The results found that 93% of individuals in the high-risk group presented persistently positive antiphospholipid antibodies, compared with 47% of individuals in the lower-risk group.

132
132